
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Don’t miss our latest news! Sign up today for our free newsletter.
By continuing to use our site, you agree to our Private Policy and Terms of Use.
People with hiv who are currently on older antiretroviral therapy may want to also keep tabs on the possibility of becoming diabetic or talk to their doctor about updating their treatments. A new study by St. Luke's-Roosevelt Hospital Center and Columbia University in New York City recommends that people with HIV be screened for diabetes routinely when starting antiretroviral therapy, with a follow-up three to six months later, and then annually. The study authors, who reviewed previous research on HIV and diabetes, made this recommendation because the rate of diabetes among HIVers on protease inhibitors is between 7% and 13%, compared to around 3% for previously untreated people with HIV, according to The AIDS Beacon. Not all treatments had the same correlation with diabetes. Among protease inhibitors, Crixivan was linked to a higher risk of diabetes, while Reyataz appeared to have no link. For Kaletra, some research showed it to be associated with a higher risk of insulin resistance, one of the indicators of diabetes, while other studies showed no effect. Other classes of drugs, particularly older nucleoside reverse transcriptase inhibitors like Zerit, Retrovir, and Videx, may also increase the chances of becoming diabetic. Some research found that the risk of high insulin levels increased 8% annually with NRTI use. However, the newer NRTI Viread, which is also a component of Atripla and Truvada, has not been tied to heightened risk of diabetes. The International AIDS Society has specific advice for HIVers trying to avoid diabetes; among them, it encourages doctors to monitor a patient's glucose and lipid levels before and during antiretroviral treatment. It also recommends that patients with a family history of diabetes be tested and, if they have the disease, manage it with a healthy diet and regular exercise (and medication, if needed).
From our Sponsors
Most Popular
Be sure to follow
Plus on your favorite social platforms!
Facebook
Instagram
Twitter
Want more news, top stories, and videos? Check out the all NEW Advocate Channel!
Your 24/7 streaming source for equality news and lifestyle trends.
Click this link right now: https://advocatechannel.com
Don’t miss our latest news! Sign up today for our free newsletter.
Plus: Featured Video